CTT Pharmaceutical Holdings, Inc.
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
OTC · BMCS · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BioTech Medics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
BioTech Medics, Inc. operates as a holding company with a focus on the medical field. The firm manages therapeutic laser clinics that deliver treatment for diverse pain conditions impacting muscles, nerves, bones, and arthritic discomfort. Among its product offerings is SHBAN, an antiseptic sanitizing solution for hands and body. Additionally, the company develops and markets nutritional supplements, including BioBody Balance, a concentrated liquid vitamin, and BioBody Energy Spray, a natural, caffeine- and alcohol-free vitamin energy spray. These nutraceutical products are distributed via general retail channels. Founded in 1997 and headquartered in Southlake, Texas, BioTech Medics maintains laser pain centers across Texas, California, New Mexico, and Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.18$0.00 (0.0%)
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
$0.00+$0.00 (+100.0%)
Herborium Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (-25.0%)
Medical Marijuana, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Yooma Wellness Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Endexx Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.
$0.00$0.00 (0.0%)
Body and Mind Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.